SmartMetric (SMME) 10-Q 19 Nov 21 2022 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Sep. 30, 2021	Nov. 15, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--06-30
Entity File Number	000-54853
Entity Registrant Name	SMARTMETRIC, INC.
Entity Central Index Key	0001301991
Entity Tax Identification Number	05-0543557
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	3960 Howard Hughes Parkway
Entity Address, Address Line Two	Suite 500
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89169
City Area Code	(702)
Local Phone Number	990-3687
Entity Current Reporting Status	Yes
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		488,648,586

Condensed Consolidated Balance

Condensed Consolidated Balance Sheet (Unaudited) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Current assets:
Cash	$ 114,043	$ 10,325
Prepaid expenses and other current assets	8,750	5,000
Total current assets	122,793	15,325
Non-current assets
Note receivable	4,980
Deferred financing costs	35,000	35,000
Total assets	162,773	50,325
Current liabilities:
Accounts payable and accrued expenses	1,097,697	1,073,786
Liability for stock to be issued	87,283	127,321
Deferred Officer’s salary	737,642	737,642
Related party interest payable	214,756	201,846
Dividends payable	3,865	2,442
Due to shareholders	41,343	41,343
Covid19 SBA loan	41,664	41,664
Convertible note payable, net of discount	316,342	35,000
Derivative liability	542,131	45,524
Convertible interest payable	4,676	3,801
Interest payable	875	875
Shareholder loan
Total current liabilities	3,088,274	2,311,244
Commitments and contingencies (See note 4) Series C Convertible Preferred Stock, net of discount, authorized 1000,000 shares, 173,084 and 196,083 shares issued and outstanding, respectively	173,084	196,083
Stockholders’ deficit:
Preferred stock, $.001 par value; 5,000,000 shares authorized, 610,000 and 610,000 shares issued and outstanding	610	610
Common stock, $.001 par value; 1,200,000,000 shares authorized, 488,648,586 and 446,385,628 shares issued and outstanding, respectively	488,649	446,386
Additional paid-in capital	26,373,605	25,955,367
Accumulated deficit	(29,961,449)	(28,859,365)
Total stockholders’ deficit	(3,098,585)	(2,457,002)
Total liabilities and stockholders’ deficit	162,773	50,325
Preferred Class A [Member]
Stockholders’ deficit:
Preferred stock, $.001 par value; 5,000,000 shares authorized, 610,000 and 610,000 shares issued and outstanding

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheet (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2021	Jun. 30, 2021
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	610,000	610,000
Preferred stock, outstanding	610,000	610,000
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	1,200,000,000	1,200,000,000
Common stock, issued	488,648,586	446,385,628
Common stock, outstanding	488,648,586	446,385,628
Series C Convertible Preferred Stock [Member]
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	173,084	196,083
Preferred stock, outstanding	173,084	196,083
Preferred Class A [Member]
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, outstanding	0	0
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001

Condensed Consolidated Statemen

Condensed Consolidated Statements Of Operations (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenues
Expenses:
Officer’s salary	47,500	47,500
Other general and administrative	492,375	124,596
Research and development	24,395	22,206
Total operating expenses	564,270	194,302
Loss from operations before income taxes	(564,270)	(194,302)
Interest & Financing Expense	(30,783)	(28,669)
Gain (loss) on change in derivatives	(505,608)	1,064
Net loss	(1,110,661)	(221,907)
Preferred stock dividends	(1,423)	(4,029)
Net loss available for common stockholders	$ (1,102,084)	$ (225,936)
Net loss per share, basic and diluted	$ 0	$ 0
Weighted average number of common shares outstanding, basic and diluted	469,331,928	381,988,718

Consolidated Statements of Chan

Consolidated Statements of Changes In Stockholder's Equity(Deficit) (Unaudited) - USD ($)	Preferred Series C Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jun. 30, 2020	$ 610	$ 379,523	$ 25,429,261	$ (27,771,062)	$ (1,961,671)
Beginning,balance shares at Jun. 30, 2020	610,000	379,523,000
Shares issued of common stock and warrants for cash
Preferred C shares Converted to Common		$ 5,447	31,921		37,368
Preferred C shares Converted to Common, Shares		5,447,260
Beneficial conversion feature related to convertible debt
Series C dividends				(4,029)	(4,029)
Shares of Common  Stock issued for services		$ 585	2,340		2,925
Shares of Common Stock issued for services, shares		585,000
Net loss for period				(221,907)	(221,907)
Ending balance, value at Sep. 30, 2020	$ 610	$ 385,555	25,463,522	(27,996,998)	(2,147,312)
Ending,balance shares at Sep. 30, 2020	610,000	385,555,260
Beginning balance, value at Jun. 30, 2021	$ 610	$ 446,386	25,955,367	(28,859,365)	(2,457,002)
Beginning,balance shares at Jun. 30, 2021	610,000	446,385,628
Common shares issued for services		$ 4,095	31,905		$ 36,000
Common shares issued for services (in Shares)		4,095,238			4,095,238
Shares issued of common stock and warrants for cash		$ 8,133	59,367		$ 67,500
Shares issued of common stock and warrants for cash (in Shares)		8,133,333
Shares converted from Preferred C shares to common		$ 17,535	89,466		107,001
Shares converted from Preferred C shares to common (in Shares)		17,534,387
Shares issued for finder’s fee		$ 12,500	237,500		250,000
[custom:SharesIssuedForFindersFeeShares]		12,500,000
Preferred C dividends				(1,423)	(1,423)
Net loss for period				(1,100,661)	(1,100,661)
Ending balance, value at Sep. 30, 2021	$ 610	$ 488,649	$ 26,373,605	$ (29,961,449)	$ (3,098,585)
Ending,balance shares at Sep. 30, 2021	610,000	488,648,586

Condensed Consolidated Statem_2

Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,100,661)	$ (221,907)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued and issuable for services	286,000	2,926
Non cash financing expense		13,831
Gain (loss) on fair value of derivative liability	505,608	(1,064)
Amortization of debt discount	11,342	1,677
Changes in assets and liabilities
Increase (Decrease) in prepaid expenses and other current assets	(3,750)	7,017
Increase in accounts payable and accrued expenses	23,912	17,196
(Decrease) in deferred officer salary		(15,833)
Increase in Due to shareholder
Increase in Convertible interest payable	875
Increase in accrued interest payable	12,910	13,161
Net cash used in operating activities	(263,764)	(182,996)
CASH FLOWS FROM FINANCING ACTIVITIES
Loans from related parties		1,709
Proceeds from sale of common stock	27,462	77,410
Proceeds from AJB Note	270,000
Proceeds from sale of Series C Preferred stock	75,000	60,000
Advance for note	(4,980)
Net cash provided by financing activities	367,482	139,119
NET INCREASE (DECREASE) IN CASH	103,718	(43,877)
CASH BEGINNING OF PERIOD	10,325	71,377
END OF PERIOD	114,043	27,500
CASH PAID DURING THE PERIOD FOR:
Income taxes

Condensed Consolidated Statem_3

Condensed Consolidated Statements Of Cash Flows (Unaudited) (Parenthetical) - shares	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Conversion of shares	17,534,387
Common Stock [Member]
Number of shares issued	17,534,387	21,482,136
Series C Preferred Stock [Member]
Conversion of shares	116,050	72,600

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	3 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 ORGANIZATION AND BASIS OF PRESENTATION SmartMetric, Inc. (the “Company” or “SmartMetric”) was incorporated in the State of Nevada on December 18, 2002. SmartMetric’s main product is a fingerprint sensor-activated card with a finger sensor onboard the card and a built-in rechargeable battery for portable biometric identification. This card may be referred to as a biometric card or the SmartMetric Biometric Datacard. SmartMetric has completed development of its card along with pre-mass manufacturing cards but has not yet begun to mass manufacture the biometric fingerprint activated cards. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management of the Company, the accompanying unaudited financial statements contain all the adjustments (which are of a normal recurring nature) necessary for a fair presentation. Operating results for the three months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending June 30, 2022. For further information, refer to the financial statements and the footnotes thereto contained in the Company’s Annual Report on Form 10-K for the year ended June 30, 2021, as filed with the Securities and Exchange Commission on October 12, 2021. The consolidated balance sheet as of June 30, 2021, has been derived from the audited financial statements at that date, but does not include all the information and footnotes required by US GAAP for complete financial statements. Going Concern As shown in the accompanying condensed consolidated financial statements the Company has sustained recurring losses of $ 1,100,661 29,961,449 These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date of this filing. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The COVID-19 has had an impact on SmartMetric’s final card production. While the delays are due to supply line disruption, the Company is confident that these delays will be short-lived based on advice from our manufacturing partners, manufacturing alternatives and alternative supply lines that are being put into place by the Company. Management believes that the Company’s capital requirements will depend on many factors. These factors include product marketing and distribution. The management plans include equity sales and borrowing in order to fund the operations. The Company plans to continue its relationship with Geneva Roth Remark in order to raise capital through cash received for issuance of Series C Convertible Preferred Stock. There are no assurances that the Company will be able to achieve the level of revenues adequate to generate sufficient cash flow from operations to support the Company’s working capital requirements. To the extent that funds generated are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, the Company may not continue its operations. In December 2019, an outbreak of a novel strain of coronavirus originated in Wuhan, China (“COVID-19”) and has since spread worldwide, including to the Unites States, posing public health risks that have reached pandemic proportions (the “COVID-19 Pandemic”). The COVID-19 Pandemic poses a threat to the health and economic wellbeing of our employees, customers and vendors. Like most businesses world-wide, the COVID-19 Pandemic has impacted the Company financially delaying the beginning of production. Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation and consulting costs. Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow. Loss Per Share of Common Stock In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of September 30, 2021 and 2020, 102,551,018 82,882,681 Stock-Based Compensation The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Compensation Equity-Based Payments to Non-Employees Fair value of financial instruments The Company measures fair value in accordance with ASC 820 - Fair Value Measurements. ASC 820 defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurements. ASC 820 establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by ASC 820 are: Level 1 Level 2 Level 3 As defined by ASC 820, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale, which was further clarified as the price that would be received to sell an asset or paid to transfer a liability (“an exit price”) in an orderly transaction between market participants at the measurement date. The reported fair values for financial instruments that use Level 2 and Level 3 inputs to determine fair value are based on a variety of factors and assumptions. Accordingly, certain fair values may not represent actual values of the Company’s financial instruments that could have been realized as of September 30, 2021 or that will be recognized in the future, and do not include expenses that could be incurred in an actual settlement. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, receivables from related parties, prepaid expenses and other, accounts payable, accrued liabilities, and related party and third-party notes payables approximate fair value due to their relatively short maturities. The Company’s notes payable to related parties approximates the fair value of such instrument based upon management’s best estimate of terms that would be available to the Company for similar financial arrangements at September 30, 2021.

PREPAID EXPENSES

PREPAID EXPENSES	3 Months Ended
	Sep. 30, 2021
Prepaid Expenses
PREPAID EXPENSES	NOTE 3 PREPAID EXPENSES Prepaid expenses represent the unexpired terms of various consulting agreements as well as advance rental payments. Prepaid expenses at September 30, 2021 were $ 8,750

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 4 - COMMITMENTS AND CONTINGENCIES Lease Agreement The Company’s main office is in Las Vegas, Nevada. Rent expense under all leases for the three months ended September 30, 2021 and 2020 was $ 1,325 766 Related Party Transactions As of September 30, 2021 and 2020, the Company has accrued the amounts of $ 737,642 737,642 As a result of shareholder loans and deferred officer salary, the Company has accrued a balance of $ 214,756 162,642 On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, (i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Stock may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 shares of Series B Convertible Preferred Stock. Our CEO maintains an employment agreement that stipulates a $ 190,000 Litigation From time to time we may be a defendant or plaintiff in various legal proceedings arising in the normal course of our business. As of the date of this Quarterly Report, there are no material pending legal or governmental proceedings relating to us or properties to which we are a party, and, to our knowledge, there are no material proceedings to which any of our directors, executive officers or affiliates are a party adverse to us or which have a material interest adverse to us.

DEBT

DEBT	3 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
DEBT	NOTE 5 - DEBT On April 17, 2020, we received funds under the Paycheck Protection Program, a part of the CARES Act. The loan is serviced by Chase Bank, and the application for these funds required us to, in good faith, certify that the current economic uncertainty made the loan necessary to support our ongoing operations. We used the funds for payroll and related costs. The receipt of these funds, and the forgiveness of the loan attendant to these funds, was dependent on our ability to adhere to the forgiveness criteria. The loan bears interest at a rate of 0.98% per annum and had a maturity date of April 6, 2022, with the first payment being deferred until April 17, 2021. Under the terms of the PPP, certain amounts may be forgiven if they are used in accordance with the CARES Act. The Company applied for forgiveness of this loan as of October 2021 and forgiveness was granted by the Small Business Administration. Therefore, the loan is considered paid in full. On March 5, 2020, the Company issued a $ 35,000 10 0.0175 5,000 2,127 3,804 5,000 35,000 337 341 On July 23, 2021, the Company entered into a Securities Purchase Agreement with AJB Capital Investments, LLC with respect to the sale and issuance of: (i) a commitment fee in the amount of $ 250,000 12,500,000 300,000 10,000,000 5,000 250,000 300,000 270,000 30,000 0.05 5,000 253,000 270,000 11,342

STOCKHOLDERS_ DEFICIT

STOCKHOLDERS’ DEFICIT	3 Months Ended
	Sep. 30, 2021
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 6 STOCKHOLDERS’ DEFICIT Preferred Stock Series B Preferred Stock On December 11, 2009, the Company filed a Certificate of Designation with the State of Nevada, to designate 500,000 5,000,000 The Company issued 200,000 In October 2015, the Company issued 200,000 On September 11, 2017, the Company issued an additional 210,000 As of September 30, 2021, the Company has 5,000,000 , par value $ 0.001 610,000 Holders of the Series B Convertible Preferred Stock are entitled to receive dividends or other distributions with the holders of the common stock of the Company on an as converted basis when, as, and if declared by the directors of the Company. Holders of the Series B Convertible Preferred Stock are entitled to convert each share of the Series B Convertible Preferred Stock into fifty (50) shares of common stock. Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, holders of the Series B Convertible Preferred Stock are entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, pro rata with the holders of the common stock. Series C Convertible Preferred Stock From time to time, the Company issues Series C Convertible Preferred Stock in exchange for cash. These shares are convertible into shares of the Company’s common stock. The number of issued and outstanding shares of Series C Convertible Preferred Stock were 164,083 196,083 Series D Convertible Preferred Stock On July 27, 2021 the Company designated Series D Convertible Preferred Stock (the “Series D Shares”). The Series D Shares have a stated value of $100.00 (the “Stated Value”), and carry a conversion price of the volume weighted average price (for the 20 trading days immediate prior to the conversion date. The amount of shares of Common Stock to be issued upon any conversion shall be calculated as the quotient of (i) the product of the issued shares of the Series D Shares to be converted and the Stated Value, and (ii) the Conversion Price. The Series D Shares are not entitled to receive dividends or other distributions, and have no voting rights. Common Stock During the last fiscal quarter of fiscal year ending June 30, 2021, the Company increased its authorized shares of common stock from 600,000,000 to 1,200,000,000 As of September 30, 2021, the Company had 448,648,586 488,648,586 ● During the three months ended September 30, 2021, the Company sold 5,500,000 27,462 (i) 5,500,000 shares at a price of $0.10 per share and (ii) 5,500,000 shares at a price of $0.20. The warrants expire at various times through September 21, 2022. None of the 12,000,000 shares were issued during the quarter ended September 30, 2021, and were recognized as stock payable. ● During the three months ended September 30, 2021, the Company issued 42,262,958 8,133,333 17,534,387 116,050 4,095,238 12,500,000 ● As of September 30, 2021, the Company had 448,648,586 shares of common stock issued and outstanding. Equity Financing Agreement On March 5, 2020, the Company entered into an equity financing agreement (the “Equity Financing Agreement”) with GHS Investments, LLC, a Nevada limited liability company (“GHS”). Pursuant to the Equity Financing Agreement, the Company agreed to sell to GHS an indeterminate amount of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), up to an aggregate price of four million dollars ($4,000,000). Following effectiveness of the Registration Statement, the Company shall have the discretion to deliver puts to GHS and GHS will be obligated to purchase shares of the Company’s Common Stock based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice shall not exceed two hundred percent (200%) of the average daily trading dollar volume of the Company’s Common Stock during the ten (10) trading days preceding the put, so long as such dollar amount does not exceed $500,000. Pursuant to the Equity Financing Agreement, GHS and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to GHS that would result in GHS’s beneficial ownership, equalling more than 4.99% of the Company’s outstanding Common Stock. The price of each put share shall be equal to eighty percent (80%) of the Market Price (as defined in the Equity Financing Agreement). Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the Registration Statement. Concurrently with the execution of the Equity Financing Agreement, the Company entered into a convertible promissory note, for the principal balance of $ 35,000 10 0.0175 35,000 Pursuant to the Equity Financing Agreement, the Company is required, within sixty (60) calendar days upon the date of execution of the Equity Financing Agreement, to use its best efforts to file with the SEC a registration statement or registration statements (as is necessary) on Form S-1, covering the resale of all of the registrable securities, which registration statement(s) shall state that, in accordance with Rule 416 promulgated under the 1933 Act, such registration statement also covers such indeterminate number of additional shares of Common Stock as may become issuable upon stock splits, stock dividends or similar transactions. Pursuant to the Equity Financing Agreement, the Company filed a registration statement on Form S-1 (the “Registration Statement”) on August 6, 2020. The Registration Statement has been withdrawn as of the date of this filing and never became effective. Warrants From time to time the Company granted warrants in connection with private placements of securities, as described herein. As of September 30, 2021, and June 30, 2021, the following is a breakdown of the warrant activity: Schedule of share based compensation warrant activity Range of Exercise Prices Number of Weighted- Weighted- Number Weighted- Warrants Outstanding and Exercisable at September 30, 2021: $0.10 - $0.20 102,551,018 1.27 $ 0.28 102,551,018 $ 0.28 Warrants Outstanding and Exercisable at June 30, 2021: $0.10 - $0.20 124,888,519 1.12 $ 0.33 124,888,519 $ 0.33 Warrant Activity: September 30, 2021: Schedule of warrant activity Outstanding - June 30, 2021 124,888,519 Issued 6,999,999 Exercised — Expired (29,337,500 ) Outstanding - September 30, 2021 102,551,018 September 30, 2020: Outstanding - June 30, 2020 53,280,406 Issued 32,000,000 Exercised — Expired (2,397,725 ) Outstanding - September 30, 2020 82,882,681 At September 30, 2021, all 102,551,018 102,551,018 warrants expire at various times prior to September 21, 2022.

MANDATORY REDEEMABLE CONVERTIBL

MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK	3 Months Ended
	Sep. 30, 2021
Mandatory Redeemable Convertible Preferred Stock
MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK	NOTE 7 MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK Issuances of Series C Convertible Preferred Stock On January 10, 2019, the Board of Directors of the Company adopted a resolution pursuant to the Company’s Certificate of Incorporation, as amended, providing for the designations, preferences and relative, participating, optional and other rights, and the qualifications, limitations and restrictions, of the Series C Convertible Preferred Stock. On January 14, 2019, the Company filed a Certificate of Designations for a Series C Convertible Preferred Stock. The authorized number of Series C Convertible Preferred Stock is 1,000,000 0.001 10 105 130 The number of shares of Series C Convertible Preferred Stock issued and outstanding were 173,084 196,084 The Holder shall have the right at any time during the period beginning on the date which is six (6) months following the Issuance Date, to convert all or any part of the outstanding Series C Preferred Stock into fully paid and non-assessable shares of Common Stock at the Variable Conversion Price. The “Variable Conversion Price” shall mean 71% multiplied by the Market Price (representing a discount rate of 29%). “Market Price” means the average of the two (2) lowest Trading Prices (as defined here) for the Common Stock during the fifteen (15) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. The Preferred stock is convertible after six months at 71 35,000 On the date which is eighteen (18) months following the Issuance Date or upon the occurrence of an Event of Default (the “Mandatory Redemption Date”), the Company shall redeem all of the shares of Series C Preferred Stock of the Holder (which have not been previously redeemed or converted). With five (5) days of the Mandatory Redemption Date, the Company shall make payment to each Holder of an amount in cash equal to the total number of shares of Series C Preferred Stock held by such Holder multiplied by the then current Stated Value. All shares of mandatorily redeemable convertible preferred stock have been presented outside of permanent equity in accordance with ASC 480, Classification and Measurement of Redeemable Securities i.e. The carrying value of the Series C Convertible Preferred Stock at September 30, 2021 and June 30, 2021 was $ 173,084 196,083 There were 90,750 Preferred C shares issued for net proceeds of $75,000 and 116,050 Preferred C shares converted to 17,534,387 Common shares for the three months ended September 30, 2021.

DERIVATIVE LIABILITIES

DERIVATIVE LIABILITIES	3 Months Ended
	Sep. 30, 2021
Derivative Liabilities
DERIVATIVE LIABILITIES	NOTE 8 DERIVATIVE LIABILITIES The conversion rates of the convertible notes and Series C Convertible Preferred Stock are convertible at a variable rate. Accordingly, the Company concluded there is an embedded derivative which was required to be bifurcated and accounted for as a derivative liability. The Company chose to use the Black Scholes model to calculate the derivative liability. The assumptions in the derivative liability calculation included the price of the Company’s common stock of $ 0.0141 0.0010 0.001 150 341 Schedule of fair value of derivative liability Level 1 Level 2 Level 3 Total Derivative liability $ - $ - $ 542,131 $ 542,131

INCOME TAXES

INCOME TAXES	3 Months Ended
	Sep. 30, 2021
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 9 INCOME TAXES The Company provides for income taxes at the end of each interim period based on the estimated effective tax rate for the full fiscal year. Cumulative adjustments to the Company’s estimate are recorded in the interim period in which a change in the estimated annual effective rate is determined. The Company has estimated its effective tax rate to be 0

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 SUBSEQUENT EVENTS In accordance with ASC 855-10, the Company has reviewed its operations subsequent to September 30, 2021 to the date these financial statements were issued. Between January 1, 2021 and March 31, 2021, the Company issued 26,769,540 17,500,000 6,709,100 2,560,440

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.
Research and Development	Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation and consulting costs.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.
Loss Per Share of Common Stock	Loss Per Share of Common Stock In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of September 30, 2021 and 2020, 102,551,018 82,882,681
Stock-Based Compensation	Stock-Based Compensation The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Compensation Equity-Based Payments to Non-Employees
Fair value of financial instruments	Fair value of financial instruments The Company measures fair value in accordance with ASC 820 - Fair Value Measurements. ASC 820 defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurements. ASC 820 establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by ASC 820 are: Level 1 Level 2 Level 3 As defined by ASC 820, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale, which was further clarified as the price that would be received to sell an asset or paid to transfer a liability (“an exit price”) in an orderly transaction between market participants at the measurement date. The reported fair values for financial instruments that use Level 2 and Level 3 inputs to determine fair value are based on a variety of factors and assumptions. Accordingly, certain fair values may not represent actual values of the Company’s financial instruments that could have been realized as of September 30, 2021 or that will be recognized in the future, and do not include expenses that could be incurred in an actual settlement. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, receivables from related parties, prepaid expenses and other, accounts payable, accrued liabilities, and related party and third-party notes payables approximate fair value due to their relatively short maturities. The Company’s notes payable to related parties approximates the fair value of such instrument based upon management’s best estimate of terms that would be available to the Company for similar financial arrangements at September 30, 2021.

STOCKHOLDERS_ DEFICIT (Tables)

STOCKHOLDERS’ DEFICIT (Tables)	3 Months Ended
	Sep. 30, 2021
Equity [Abstract]
Schedule of share based compensation warrant activity	Schedule of share based compensation warrant activity Range of Exercise Prices Number of Weighted- Weighted- Number Weighted- Warrants Outstanding and Exercisable at September 30, 2021: $0.10 - $0.20 102,551,018 1.27 $ 0.28 102,551,018 $ 0.28 Warrants Outstanding and Exercisable at June 30, 2021: $0.10 - $0.20 124,888,519 1.12 $ 0.33 124,888,519 $ 0.33
Schedule of warrant activity	Schedule of warrant activity Outstanding - June 30, 2021 124,888,519 Issued 6,999,999 Exercised — Expired (29,337,500 ) Outstanding - September 30, 2021 102,551,018 September 30, 2020: Outstanding - June 30, 2020 53,280,406 Issued 32,000,000 Exercised — Expired (2,397,725 ) Outstanding - September 30, 2020 82,882,681

DERIVATIVE LIABILITIES (Tables)

DERIVATIVE LIABILITIES (Tables)	3 Months Ended
	Sep. 30, 2021
Derivative Liabilities
Schedule of fair value of derivative liability	Schedule of fair value of derivative liability Level 1 Level 2 Level 3 Total Derivative liability $ - $ - $ 542,131 $ 542,131

ORGANIZATION AND BASIS OF PRE_2

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Recurring losses	$ 1,100,661	$ 221,907
Accumulated deficit	$ 29,961,449		$ 28,859,365

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - shares	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Accounting Policies [Abstract]
Dilutive shares were excluded from diluted loss per common share	102,551,018	82,882,681

PREPAID EXPENSES (Details Narra

PREPAID EXPENSES (Details Narrative)	Sep. 30, 2021USD ($)
Prepaid Expenses
Prepaid expenses	$ 8,750

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	Sep. 11, 2017	Sep. 30, 2021	Jun. 30, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Rent expense		$ 1,325	$ 766
Accrued the amounts		737,642	737,642
Interest Payable		214,756	$ 162,642
Annual salary		$ 190,000
Chief Executive Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Related party transactions, description	(i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Stock may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 shares of Series B Convertible Preferred Stock.

DEBT (Details Narrative)

DEBT (Details Narrative) - USD ($)	Mar. 05, 2020	Jul. 23, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Jun. 30, 2021
Debt Instrument [Line Items]
Convertible note	$ 35,000		$ 316,342			$ 35,000
Convertible note, percentage	10.00%
Beneficial conversion feature	$ 5,000
Amortization of Debt Discount			11,342	1,677	$ 5,000	$ 2,127
Amortization of debt discount				$ 3,804
Unamortized discount			$ 35,000
Volatility rate, minimum			150.00%
Volatility rate, maximum			341.00%
Securities Purchase Agreement [Member] | A J B Capital Investments [Member]
Debt Instrument [Line Items]
Amortization of Debt Discount			$ 11,342
Stock issued for commitment fee, amount		$ 250,000
Stock issued for commitment fee, Shares		12,500,000
Principal amount		$ 300,000
Warrants purchased		10,000,000
Purchase Price		$ 270,000
Original issue discount		$ 30,000
Exercise Price		$ 0.05
Notes and warrants due		$ 253,000
Securities Purchase Agreement [Member] | A J B Capital Investments [Member] | Series D Preferred Stock [Member]
Debt Instrument [Line Items]
Shares issued		5,000
Conversion of Stock, Shares Issued		5,000
Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Conversion price per share (in Dollars per share)	$ 0.0175
Convertible Debt [Member]
Debt Instrument [Line Items]
Volatility rate, minimum			337.00%
Volatility rate, maximum			341.00%

STOCKHOLDERS' DEFICIT (Details)

STOCKHOLDERS' DEFICIT (Details) - $ / shares	3 Months Ended	12 Months Ended
	Sep. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Mar. 31, 2021
Equity [Abstract]
Number of Warrants Outstanding (in Shares)	102,551,018		124,888,519
Weighted-Average Contractual Life Remaining in Years	1 year 3 months 7 days	1 year 1 month 13 days
Weighted- Average Exercise Price	$ 0.28		$ 0.33
Number Exercisable (in Shares)			124,888,519	102,551,018
Weighted- Average Exercise Price	$ 0.28		$ 0.33

STOCKHOLDERS' DEFICIT (Details

STOCKHOLDERS' DEFICIT (Details 1) - shares	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Equity [Abstract]
Outstanding - beginning of year	124,888,519	53,280,406
Issued	6,999,999	32,000,000
Exercised
Expired	(29,337,500)	(2,397,725)
Outstanding - end of year	102,551,018	82,882,681

STOCKHOLDERS_ DEFICIT (Details

STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)	Mar. 05, 2020	Sep. 11, 2017	Oct. 31, 2015	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2021	Jan. 14, 2019	Nov. 05, 2014	Dec. 11, 2009
Class of Stock [Line Items]
Preferred stock, shares authorized				5,000,000			5,000,000
Preferred stock, par value (in Dollars per share)				$ 0.001			$ 0.001
Preferred stock, shares issued				610,000			610,000
Preferred stock, outstanding				610,000			610,000
Common stock, shares authorized				1,200,000,000			1,200,000,000
Common Stock, Shares, Outstanding				488,648,586			446,385,628
Common stock, shares issued				488,648,586			446,385,628
Number of common stock sold				5,500,000
Proceeds from sale of common stock				$ 27,462		$ 77,410
Warrants to purchase shares, description					(i) 5,500,000 shares at a price of $0.10 per share and (ii) 5,500,000 shares at a price of $0.20.  The warrants expire at various times through September 21, 2022. None of the 12,000,000 shares were issued during the quarter ended September 30, 2021, and were recognized as stock payable.
Number of common stock issued				42,262,958
Stock issued for stock payable				8,133,333	17,500,000
Number of stock converted				17,534,387	6,709,100
Shares issued for legal services				4,095,238	2,560,440
Finders fee				$ 12,500,000
Registration Statement, description	the Company shall have the discretion to deliver puts to GHS and GHS will be obligated to purchase shares of the Company’s Common Stock based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice shall not exceed two hundred percent (200%) of the average daily trading dollar volume of the Company’s Common Stock during the ten (10) trading days preceding the put, so long as such dollar amount does not exceed $500,000. Pursuant to the Equity Financing Agreement, GHS and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to GHS that would result in GHS’s beneficial ownership, equalling more than 4.99% of the Company’s outstanding Common Stock. The price of each put share shall be equal to eighty percent (80%) of the Market Price (as defined in the Equity Financing Agreement). Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the Registration Statement.
Class of warrants expire				102,551,018
Convertible Promissory Note [Member]
Class of Stock [Line Items]
Principal balance (in Dollars)	$ 35,000,000
Interest rate, percentage	1000.00%
Fixed conversion price (in Dollars per share)	$ 0.0175
Deferred financing costs (in Dollars)	$ 35,000,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock shares										500,000
Preferred stock shares increased									5,000,000
Number of shares issued		210,000	200,000	200,000
Preferred stock, shares authorized				5,000,000
Preferred stock, par value (in Dollars per share)				$ 0.001
Preferred stock, shares issued				610,000
Preferred stock, outstanding				610,000
Stock issued				116,050
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares issued				164,083
Preferred stock, outstanding				164,083
Number of stock converted				116,050		72,600
Series C Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized				1,000,000			1,000,000	1,000,000
Preferred stock, par value (in Dollars per share)								$ 0.001
Preferred stock, shares issued				173,084			196,083
Preferred stock, outstanding				173,084			196,083

MANDATORY REDEEMABLE CONVERTI_2

MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative) - USD ($)	Jan. 14, 2019	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020
Preferred stock, authorized (in Shares)		5,000,000	5,000,000
Preferred stock, par value (in Dollars per share)		$ 0.001	$ 0.001
Preferred stock shares issued (in Shares)		610,000	610,000
Preferred stock shares outstanding (in Shares)		610,000	610,000
Preferred shares convertible average market price rate		71.00%
Amortized utilizing effective interest discount amount (in Dollars)				$ 35,000,000
Series C Convertible Preferred Stock [Member]
Preferred stock, authorized (in Shares)	1,000,000	1,000,000	1,000,000
Preferred stock, par value (in Dollars per share)	$ 0.001
Dividend percent	10.00%
Preferred stock shares issued (in Shares)		173,084	196,083
Preferred stock shares outstanding (in Shares)		173,084	196,083
Description of conversion of stock		The Holder shall have the right at any time during the period beginning on the date which is six (6) months following the Issuance Date, to convert all or any part of the outstanding Series C Preferred Stock into fully paid and non-assessable shares of Common Stock at the Variable Conversion Price. The “Variable Conversion Price” shall mean 71% multiplied by the Market Price (representing a discount rate of 29%). “Market Price” means the average of the two (2) lowest Trading Prices (as defined here) for the Common Stock during the fifteen (15) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date.
Fair value of convertible preferred stock (in Dollars)				$ 173,084,000	$ 196,083,000
Preferred shares, description		There were 90,750 Preferred C shares issued for net proceeds of $75,000 and 116,050 Preferred C shares converted to 17,534,387 Common shares for the three months ended September 30, 2021.
Series C Convertible Preferred Stock [Member] | Minimum [Member]
Dividend percent	105.00%
Series C Convertible Preferred Stock [Member] | Maximum [Member]
Dividend percent	130.00%
Series C Convertible Preferred Stocks [Member]
Preferred stock shares issued (in Shares)		173,084	196,084
Preferred stock shares outstanding (in Shares)		173,084	196,084

DERIVATIVE LIABILITIES (Details

DERIVATIVE LIABILITIES (Details) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Defined Benefit Plan Disclosure [Line Items]
Derivative liability	$ 542,131	$ 45,524
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability	$ 542,131

DERIVATIVE LIABILITIES (Detai_2

DERIVATIVE LIABILITIES (Details Narrative)	3 Months Ended
	Sep. 30, 2021$ / shares
Derivative Liabilities
Share Price	$ 0.0141
Risk free rate, Minimum	0.10%
Risk free rate, Maximum	0.10%
Volatility rate, Minimum	150.00%
Volatility rate, Maximum	341.00%

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative)	3 Months Ended
	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Effective income tax rate reconciliation, percentage	0.00%

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - shares	3 Months Ended
	Sep. 30, 2021	Mar. 31, 2021
Issue of common shares	42,262,958
Share issued for stock payable	8,133,333	17,500,000
Number of shares converted	17,534,387	6,709,100
Shares issued for legal services	4,095,238	2,560,440
Common Stock [Member]
Issue of common shares		26,769,540
Shares issued for legal services	4,095,238